Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the pharmacokinetics, pharmacodynamics, and safety of canagliflozin in older children and adolescents with type 2 diabetes mellitus; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Invokana (canagliflozin) (canagliflozin)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED